EMP1 and breast cancer: Research has shown that the epithelial membrane protein 1 (EMP1) plays a critical role in metastatic relapse of colorectal cancer, and Zhou et al. found its impact on the prognosis and immunotherapy outcomes in BC patients 32, 33.